MediGain Services takes over MedBE
MedBE is involved in providing commercial services including revenue cycle management (RCM) and practice management to physicians throughout Louisiana and the Southeastern US. MedBE CEO Billy Chrysonthopolous said
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
Under the cooperative research and development agreement, Kite will develop engineered peripheral blood autologous T cell therapeutics (eACT), which contains proprietary tumor-specific T Cell Receptors (TCRs) and Chimeric